The Angeles Clinic & Research Institute | February 20

12:00 PM ET

Welcome & Introductions
Lawrence D. Piro, MD
President and CEO
The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation

12:20 PM ET

Multidisciplinary Care in Melanoma
Omid Hamid, MD
Chief, Translational Research and Immunotherapy
Director, Phase One Trials Program
The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation

12:40 PM ET

Surgical Considerations for Melanoma
Mark B. Faries, MD
Head of Surgical Oncology
Co-Director, Melanoma Program
The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation

1:00 PM ET

Adjuvant and Neoadjuvant Dilemmas
Jeffrey S. Weber, MD, PhD
Deputy Director
Co-Director, Melanoma Research Program
The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center

1:20 PM ET

Targeted Agents Today and Tomorrow
Ryan J. Sullivan, MD
Assistant Professor, Medicine, Harvard Medical School
Assistant Professor, Hematology/Oncology
Massachusetts General Hospital

1:40 PM ET

Future Therapies, Newer Targets
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation

2:00 PM ET

Seeking Answers: Ocular Melanoma Making Strides
Richard D. Carvajal, MD
Department of Medicine
Division of Hematology/Oncology
Co-Leader, Precision Oncology and Systems Biology Program
Director, Experimental Therapeutics
Director, Melanoma Service
Columbia University Medical Center

2:20 PM ET

Q&A With All Panelists